---
title: "Characteristics of Regulatory Approval of Innovative vs. Non-Innovative Cancer Drugs, Health Policy"
publishDate: "2019-08-29T00:00:00Z"
authors: 
 - knvokinger_author
 - Aaron S. Kesselheim
publication_types: ["2"]
abstract: "To determine differences in the characteristics of cancer drugs designated as orphan drugs by the Food and Drug Administration (FDA) and European Medicines Agency (EMA)."
featured: False
share: false
publication: "*British Medical Journal (BMJ)*"
url_pdf: "https://bmjopen.bmj.com/content/bmjopen/9/10/e028634.full.pdf"
doi: "http://dx.doi.org/10.1136/bmjopen-2018-028634"
---

